Skip to content

ANDOCOR: what changed

BE 0458.952.035NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€945,405
2024 · €2.1m-€1.1m
Equity
€4.7m
2024 · €3.7m+€945,405
Cash
€1.7m
2024 · €1.4m+€251,585
Balance sheet total
€12.3m
2024 · €13.6m-€1.3m

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets +€1.1m

    up €1.1m (+1,673%), from €64,416 to €1.1m

  • Stocks and contracts -€1.0m

    down €1.0m (-37.7%), from €2.7m to €1.7m

  • Receivables within one year -€854,111

    down €854,111 (-28.4%), from €3.0m to €2.1m

    of which Trade receivables: -€866,327

  • Tangible fixed assets -€777,240

    down €777,240 (-12.2%), from €6.4m to €5.6m

    of which Leasing and similar rights: -€509,542

  • Cash +€251,585

    up €251,585 (+17.8%), from €1.4m to €1.7m

    mainly Stocks and contracts (+€1.0m) and Depreciation (+€987,878)

Equity and liabilities
  • Other debts -€2.3m

    down €2.3m (-89.3%), from €2.6m to €273,232

  • Profit (loss) carried forward +€945,405

    up €945,405 (+25.7%), from €3.7m to €4.6m

  • Debts after one year -€676,400

    down €676,400 (-12.2%), from €5.5m to €4.9m

  • Trade debts +€621,095

    up €621,095 (+89.8%), from €691,468 to €1.3m

Income statement
  • Gross operating margin -€759,131

    down €759,131 (-15.2%), from €5.0m to €4.2m

  • Depreciation +€129,607

    up €129,607 (+15.1%), from €858,271 to €987,878

  • Taxes +€123,493

    up €123,493 (+159%), from €77,913 to €201,406

  • Staff costs +€112,815

    up €112,815 (+6.2%), from €1.8m to €1.9m

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €2.1m
Gross operating margin -€759,131
Staff costs -€112,815
Depreciation -€129,607
Provisions +€1,825
Other operating charges +€1,518
Financial income +€7,200
Financial charges -€26,819
Taxes -€123,493
Result 2025 €945,405
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€2.2m
Investment -€1.3m
Financing -€679,435
Cash 2024 €1.4m
Net result for the year +€945,405
Depreciation +€987,878
Stocks and contracts +€1.0m
Receivables within one year +€854,111
Deferred charges and accrued income -€25,380
Provisions -€3,697
Trade debts +€621,095
Tax, wage and social debts +€101,084
Other debts -€2.3m
Accrued charges and deferred income +€13,228
Investment in fixed assets (net) -€1.3m
Debts after one year -€676,400
Current portion of long-term debt -€3,035
Cash 2025 €1.7m
brings cash intakes cash out
Every line side by side 57 lines
Line Code 2024 2025 Change %
Total assets 20/58 €13,572,306 €12,283,434 -€1.3m -9.5%
Fixed assets 21/28 €6,436,454 €6,736,807 +€300,353 +4.7%
Intangible fixed assets 21 €64,416 €1,142,009 +€1.1m +1,673%
Tangible fixed assets 22/27 €6,354,685 €5,577,445 -€777,240 -12.2%
Land and buildings 22 €50,014 €45,294 -€4,721 -9.4%
Plant, machinery and equipment 23 €588,216 €386,388 -€201,828 -34.3%
Furniture and vehicles 24 €245,157 €184,007 -€61,149 -24.9%
Leasing and similar rights 25 €5,471,298 €4,961,756 -€509,542 -9.3%
Financial fixed assets 28 €17,353 €17,353 = 0.0%
Current assets 29/58 €7,135,851 €5,546,627 -€1.6m -22.3%
Stocks and contracts in progress 3 €2,687,669 €1,675,590 -€1.0m -37.7%
Stocks 30/36 €2,687,669 €1,675,590 -€1.0m -37.7%
Amounts receivable within one year 40/41 €3,003,417 €2,149,307 -€854,111 -28.4%
Trade receivables 40 €3,002,341 €2,136,014 -€866,327 -28.9%
Other amounts receivable 41 €1,076 €13,293 +€12,216 +1,135%
Cash at bank and in hand 54/58 €1,413,278 €1,664,863 +€251,585 +17.8%
Deferred charges and accrued income 490/1 €31,487 €56,867 +€25,380 +80.6%
Total equity and liabilities 10/49 €13,572,306 €12,283,434 -€1.3m -9.5%
Equity 10/15 €3,749,536 €4,694,941 +€945,405 +25.2%
Contributions 10/11 €61,973 €61,973 = 0.0%
Capital 10 €61,973 €61,973 = 0.0%
Issued capital 100 €61,973 €61,973 = 0.0%
Reserves 13 €8,655 €8,655 = 0.0%
Non-distributable reserves 130/1 €6,197 €6,197 = 0.0%
Legal reserve 130 €6,197 €6,197 = 0.0%
Distributable reserves 133 €2,458 €2,458 = 0.0%
Profit (loss) carried forward 14 €3,678,907 €4,624,312 +€945,405 +25.7%
Provisions and deferred taxes 16 €168,340 €164,643 -€3,697 -2.2%
Provisions for liabilities and charges 160/5 €168,340 €164,643 -€3,697 -2.2%
Other liabilities and charges 164/5 €168,340 €164,643 -€3,697 -2.2%
Amounts payable 17/49 €9,654,430 €7,423,850 -€2.2m -23.1%
Amounts payable after more than one year 17 €5,546,732 €4,870,331 -€676,400 -12.2%
Financial debts 170/4 €5,546,732 €4,870,331 -€676,400 -12.2%
Amounts payable within one year 42/48 €4,107,698 €2,540,291 -€1.6m -38.2%
Current portion of amounts payable after more than one year 42 €671,442 €668,407 -€3,035 -0.5%
Trade debts 44 €691,468 €1,312,563 +€621,095 +89.8%
Suppliers 440/4 €691,468 €1,312,563 +€621,095 +89.8%
Taxes, remuneration and social security 45 €185,006 €286,090 +€101,084 +54.6%
Taxes 450/3 €131,655 €233,919 +€102,264 +77.7%
Remuneration and social security 454/9 €53,351 €52,171 -€1,180 -2.2%
Other amounts payable 47/48 €2,559,783 €273,232 -€2.3m -89.3%
Accrued charges and deferred income 492/3 - €13,228 +€13,228
Remuneration, social security and pensions 62 €1,818,125 €1,930,939 +€112,815 +6.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €858,271 €987,878 +€129,607 +15.1%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 -€1,873 -€3,697 -€1,825 -97.4%
Other operating charges 640/8 €2,217 €700 -€1,518 -68.5%
Gross operating margin 9900 €4,979,455 €4,220,323 -€759,131 -15.2%
Operating profit (loss) 9901 €2,302,714 €1,304,504 -€998,210 -43.3%
Financial income 75/76B €26,810 €34,010 +€7,200 +26.9%
Recurring financial income 75 €26,810 €21,490 -€5,320 -19.8%
Non-recurring financial income 76B - €12,520 +€12,520
Financial charges 65/66B €164,884 €191,703 +€26,819 +16.3%
Recurring financial charges 65 €164,884 €191,703 +€26,819 +16.3%
Profit (loss) for the period before taxes 9903 €2,164,640 €1,146,811 -€1.0m -47.0%
Income taxes 67/77 €77,913 €201,406 +€123,493 +159%
Profit (loss) for the period 9904 €2,086,727 €945,405 -€1.1m -54.7%
Profit (loss) for the period to be appropriated 9905 €2,086,727 €945,405 -€1.1m -54.7%

Value

latest balance sheet 30-06-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€6.0m to €7.7m

Midpoint €6.7m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €3.6m
Capitalised earnings €8.5m to €11.9m
Indication €6.0m to €7.7m

Adjusted equity

balance sheet 30-06-2025
Equity (10/15)
€4,694,941
Intangible fixed assets (21)
-€1,142,009
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€3.6m

Capitalised earnings

net result for the year (9904)
2025
€945,405
excluding non-recurring income and charges
€932,885
2024
€2,086,727
2023
€567,049
excluding non-recurring income and charges
€545,138
2022
€1,698,559
excluding non-recurring income and charges
€1,698,040
2021
€780,999
Average result, excluding non-recurring income and charges
€1,188,250
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€8.5m / €9.9m / €11.9m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 30 June 2024 and 30 June 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.